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Summary
Objective: In order to develop a hand assessment questionnaire for a population survey, a systematic review was undertaken of measures of
hand disability. The purpose of this review was to identify valid measures to evaluate hand osteoarthritis (HOA) in the general population and
primary care and to perform a quality appraisal of them.
Method: Measurement tools were identiﬁed from an online search of databases (Medline, CINAHL and Institute for Scientiﬁc Information (ISI),
1990e2002) restricted to English language and adult population. Search terms combined ‘‘osteoarthritis’’ and ‘‘arthritis’’ with ‘‘hand’’ and
[‘‘function’’ or ‘‘disability’’ or ‘‘outcome’’]. Instruments used in the evaluation of HOA were identiﬁed following application of strict eligibility
criteria. The use of these tools in HOA was rated by pairs of independent reviewers according to criteria developed by the Medical Outcomes
Trust.
Results: The initial search yielded a list of articles which were not mutually exclusive (ISI, 127; Medline, 64; CINAHL, 61). Full journal articles
were ordered from relevant abstracts (ISI, 28; Medline, 3; CINAHL, 5). Further hand searching of articles produced an additional 34
references. A total of 61 references were identiﬁed, 18 measurement tools, 5 of which met the inclusion criteria [Algofunctional Index (FIHOA),
Arthritis Impact Measurement Scale 2 (AIMS2), Stanford Health Assessment Questionnaire (HAQ), Australian/Canadian Osteoarthritis Hand
Index (AUSCAN), Cochin]. Overall, the AIMS2 and AUSCAN were more highly rated than the FIHOA, Cochin and HAQ.
Conclusions: The aim of this review was not to recommend any one instrument over another but to provide an overall summary of the
robustness of commonly used measures. The choice of instrument will depend on many factors, and will differ from project to project
depending on the question asked.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is common in older people and often
affects the hip, knee and hand1. It is a cause of pain,
stiffness and disability, and limits activities of daily life2. The
impact of arthritis can be measured within dimensions as
deﬁned by the WHO ICF3, disability (activity limitation)
being frequently measured because of its importance to
patients and the lack of measures of participation (formerly
handicap). An overview of measurement of health status
in arthritis patients carried out in 1993 by Jacobs et al.4
listed 12 arthritis speciﬁc measures and assessed three
dimensions of health: function, psychosocial and social. The
two most commonly used instruments were the Stanford
Health Assessment Questionnaire (HAQ) and the Arthritis
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three dimensions, the HAQ two (function and social).
There have been few community studies of the extent of
disability caused by symptomatic hand OA (HOA) in older
people5, although the effects of limitation on quality of
activities of daily living (ADL) may be considerable6.
Population studies of hip and knee OA use disease and
region-speciﬁc measures to evaluate pain and disability,
e.g., Western Ontario and McMaster Universities Osteoar-
thritis Index (WOMAC)7,8. However, no such widely
accepted measure is recognised in HOA. The advantage
of having a common measure in population studies is that it
allows for comparability of data across populations.
In order to develop a hand assessment questionnaire for
a population survey, a systematic review was undertaken of
measures of hand disability. The purpose of this review was
to identify current valid measures to evaluate HOA in the
general population and primary care and to perform a quality
appraisal of such instruments.
Methods
A three-stage strategy was used. Stage 1 involved
identifying relevant articles using a systematic search
(where more than one article might identify a particular1
2 K. S. Dziedzic et al.: Systematic review hand OA disabilityinstrument). Stage 2 identiﬁed eligible instruments from the
articles in stage 1 for inclusion in the critical review. Stage 3
applied established review criteria to these instruments.
STAGE 1: SELECTING THE PAPERS
Search strategy
A systematic search strategy was developed. Publica-
tions were retrieved by an online electronic search of
databases (Medline, CINAHL and Institute for Scientiﬁc
Information (ISI), 1990e2002) in the English language and
adult population. All papers published until December 2002
were eligible for inclusion in the review. Search terms
combined: ‘‘osteoarthritis’’ and ‘‘arthritis’’ with ‘‘hand’’ and
[‘‘function’’ or ‘‘disability’’ or ‘‘outcome’’]. The initial search
yielded the following articles from the respective databases:
ISI (127), Medline (64) and CINAHL (61). Selection criteria
(see below) were applied to these abstracts and full papers
were retrieved if the abstract provided insufﬁcient informa-
tion to enable selection. From abstracts and application of
inclusion and exclusion criteria, full journal articles were
ordered (ISI, 28; Medline, 3; CINAHL, 5) (ISI: Refs.1,9e35,
Medline: Refs.36e38, CINAHL: Refs.39e43). References of all
identiﬁed articles were hand searched for additional
potentially relevant publications which produced an addi-
tional 30 articles plus 4 abstracts (articles: Refs.4,44e72,
abstracts: Refs.73e76).
Selection criteria
Articles were included in stage 1 if the following
conditions were met: published studies encompassing
patient assessed evaluation of functional disability in
populations with HOA (1990e2002) or published articles
referring to development or testing of patient assessed
measures of functional disability applied in HOA
(1990e2002). Exclusion criteria for stage 1 were: articles
not speciﬁc to the evaluation of patient assessed hand
disability in OA; non-English language articles; develop-
ment, testing or use of laboratory radiographic and imaging
techniques or objective measures of hand disability; articles
which did not describe the instrument in sufﬁcient detail;
non-published data; narrative reviews; single item meas-
ures; and generic measurement tools.
STAGE 2: SELECTING THE INSTRUMENTS
Quality assessment
In order to conﬁrm eligibility of disability measures,
inclusion and exclusion criteria were applied to the identiﬁed
instruments. This necessitated a further database search by
named instrument. The inclusion criteria for stage 2 were:
the tool was a published (anglicised) patient assessed
functional disability measure and had been applied in the
evaluation of HOA. Exclusion criteria for stage 2 were: an
instrument used only in relation to other hand conditions,
e.g., carpal tunnel syndrome or other types of arthritis such
as rheumatoid arthritis (RA); assessment based on objec-
tive measures of hand disability (laboratory, radiographic
and imaging techniques); instruments not clearly identiﬁed
in published texts; instruments not described in sufﬁcient
detail to allow quality assessments77; measures not
evaluating patient assessed hand disability in OA; instru-
ments only used in auditing outcome following surgery or
trauma; non-English language articles.STAGE 3: ASSESSING THE INSTRUMENTS
Review criteria
Systematic reviewing of outcome measures has been
performed previously, for example in the area of adult
critical care78. However, the criteria for systematically
reviewing outcome measurements are not as well de-
veloped as those used for randomised controlled trials
(RCTs). To evaluate how valid, reliable and appropriate the
disability measures deﬁned by the systematic search were,
we adopted the review criteria used by Coons et al.77,
published by Lohr et al.79, and developed by the Scientiﬁc
Advisory Committee of the Medical Outcomes Trust. The
review criteria (Appendix 1) consisted of: conceptual
and measurement model; reliability; validity; respondent
and administrative burden; alternate forms; and cultural and
language adaptations. For the purpose of this review, which
was to identify measures for general population surveys, we
additionally considered if the measurement tool was self-
administered, if it had been used previously in populations
with HOA, and whether the tool was a relevant measure for
population-based studies. The review also evaluated each
instrument according to the Outcome Measures in Rheu-
matology (OMERACT) group ﬁlter for outcome measures80.
The review did not seek to assess if a particular instrument
had been used as a primary outcome measure in RCTs, but
its use in trials was reported if identiﬁed. Each instrument
was reviewed by two out of the three reviewers, working
independently of each other. KD reviewed all papers with
ET or EMH acting as the second reviewer. Agreement was
achieved through consensus meetings. For each criterion
reviewed, the adequacy of supporting evidence was rated
as extensive (CCC), adequate (CC), limited (C), none
(0) and unknown (?).
Results
STAGE 1
A total of 61 references were used to identify the
measurement tools. Following the application of the stage
1 inclusion/exclusion criteria to these articles, 18 measure-
ment tools were identiﬁed: the Michigan Hand Outcomes
Questionnaire (MHOQ)15,16, the Disabilities of the Arm
Shoulder and Hand (DASH)32,45,49,50,70, the Arthritis Impact
Measurement Scales 1 and 2 (AIMS1/AIMS2)62, the
HAQ72, the Algofunctional Index (FIHOA)20,21,31, the
Disability Schedule of Function (DSF)42, the Upper Extrem-
ity Function Scale (UEFS)38,65, the Brigham and Women’s
Hospitals’ Carpal Tunnel Questionnaire (BWH CTQ)9,10,53,
the ADL and visual analogue scale (VAS) Quality of Life
Hand questionnaire (ADL/VAS QOL Hand Q)17, the
Australian/Canadian Osteoarthritis Hand Index (AUS-
CAN)12,13,29,74, the Musculoskeletal Functional Assessment
Questionnaire (MFAQ)46,57,58,69, the Instrument of Activities
of Daily Living (IADL)63, the Cochin scale22,33, the Ghent
functional index31,71, the Hand Clinic Questionnaire
(HCQ)68, the Patient Evaluation Measure (PEM)56,68, the
Hand Outcome Survey Sheet (HOSS)68 and the Hand
Injury Severity Scoring System (HISS)44,68.
STAGE 2
Following a further database search and application of
the stage 2 inclusion/exclusion criteria ﬁve instruments
were eligible for the critical review: the HAQ72, AIMS62,
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most frequent reasons for exclusion were because the
measure (1) had not been used to evaluate hand disability
in OA (UEFS38,65, BWH CTQ9,10,53, MFAQ46,57,58,69,
IADL63, HCQ68, PEM56,68, HOSS68 and HISS44,68), and
(2) was not described in sufﬁcient detail to allow quality
assessment (DSF42, ADL/VAS QOL Hand Q17, Ghent
functional index31,71). The MHOQ15,16 was excluded fol-
lowing communication with the authors because it had not
been tested in HOA. The DASH32,45,49,50 was excluded as
there was no clear evidence for its use in HOA other than in
auditing outcome following hand surgery70.
STAGE 3
A narrative review of the HAQ, AIMS, AUSCAN, Cochin
and FIHOA, supported by references identiﬁed using the
further database search by named instrument, is detailed
below.
HEALTH ASSESSMENT QUESTIONNAIRE
Background
The HAQ Disability Index (DI) was developed as part of
a comprehensive assessment of outcome in arthritis
covering multidimensional areas including death, discom-
fort, disability, drug and therapeutic costs, toxicity and dollar
costs81. The DI section of the full HAQ is normally referred
to as the ‘HAQ’. Pincus et al.82 reported on a modiﬁed HAQ
(MHAQ) with added areas such as patient satisfaction and
change in degree of difﬁculty. Baron et al.83 developed an
upper extremity HAQ score (HAQUP) which used the mean
score of dressing and grooming, eating, reach and grip. The
same version is referred to as the upper limb HAQ
(ULHAQ)84. Pincus et al.85 developed components of the
HAQ to overcome the ‘ﬂoor effects’ of the HAQ and
MHAQ86,87 and produced a new Multidimensional HAQ
(MDHAQ) for use in all types of arthritis.
Conceptual framework
The HAQ was conceptualised by Fries et al.81 as an
instrument covering outcomes important to patients. Its
multidimensionality gave a meaningful way of measuring
a number of domains without combining them into a single
score. The physical component was divided into nine
domains (with sub-scales); dressing (3), arising (1), eating
(2), walking (1), hygiene (4), reach (2), grip (3), outside
activity (2) and sex (1). Each question could be answered
on a scale ranging from ‘without difﬁculty’Z 0, ‘with
difﬁculty’Z 1, ‘with some help from another person or
device’Z 2 or ‘unable to do’Z 3. The highest score on any
sub-scale within a domain was the score for that domain.
The total score was derived by adding up the scale scores
and dividing by the number of questions answered81. The
HAQ was further reﬁned and is described in Fries et al.88. A
more recent version of the HAQ89 is described in Table I.
The HAQ has been used in long-term prospective hospital
based studies of OA patients19.
The MHAQ uses one question from each category (8/20)
with additional questions covering areas of importance82.
The MDHAQ version incorporates six advanced ADL items,
four items on psychological distress, VASs for pain and
fatigue, and the Rheumatoid Attitudes Index85. The
CLINHAQ is a version using the original HAQ and additionalitems, e.g., pain diagram, for use in clinic but that addresses
a series of domains not covered by HAQ90.
Reliability
For the HAQ, testeretest correlations in arthritis have
ranged from 0.87 to 0.9689. One-month testeretest for the
HAQ showed a correlation coefﬁcient of 0.78, and for the
MHAQ in adults with various rheumatic diseases, 0.9182.
Spearman correlations between interview and self-com-
plete formats ranged from 0.85 to 0.9489. The reliability of
the HAQUP/ULHAQ has not yet been studied separately84.
Validity
Simulation of activities in comparison with the self-
completed HAQ has been used for validation purposes81.
The HAQ and AIMS correlated well with each other (0.91,
P! 0.01) and OA patients tended to have mean lower
scores than RA patients. When assessing sensitivity to
change for HOA in RCTs, it has been difﬁcult to determine
whether the HAQ was not sensitive or if the trial was under-
powered24,91e93. Construct validity of the HAQ was
assessed and found to be valid in a UK population survey
of self-reported RA, OA and other arthritides94.
Formal validation studies of the HAQUP/ULHAQ have
not been performed per se84. However, pain severity in
older people with HOA was found to correlate with upper
limb disability measured by the HAQUP, but not hand
function tested objectively83. The HAQUP did not correlate
well with the Smith hand function test but did with strength,
pain and tenderness.
Respondent and administrative burden
Self-administration of the HAQ takes 5e8 min and can be
manually scored in less than 1 min88,89 (Table I). The
MDHAQ is completed in 10e15 min in clinic85.
Alternate forms
The HAQ has been developed for use as a self-,
interviewer-, and telephone-administered instrument.
Cultural and language adaptations
The HAQ was developed in English (USA). An anglicised
version has been developed and tested in RA patients52.
There are a number of available translations18,95,96.
Although there are a number of translations of the HAQ
and its modiﬁcations, there has been concern over the lack
of consistency in development and scoring of some of these
versions95.
Relevance to populations with
HOA in primary care
The MHAQ has been used in a UK population survey of
6000 people of all ages. This survey of musculoskeletal
complaints included older people with hand pain deﬁned as
pain in the past month lasting more than a week35. The
score was modiﬁed from that suggested by the authors82 to
that used for the original HAQ (0e3). MHAQ was not fully
completed by 11.4% responders. Upper limb symptoms
(including shoulder pain) scored less global disability on the
MHAQ compared with other musculoskeletal symptoms.
Disability levels rose with age and were especially high in
the over 75-year olds.
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Description of comparative properties of instruments
Tool
(year and country of
development)
Summary of the
instrument
Number of items Content of items Scoring method
HAQ (1980, USA) Disability index developed
as an assessment of
outcome in arthritis
20 questions in 8
domains of
function
Functional domains
include: dressing,
arising, eating,
walking, hygiene,
reach, grip, activities
Each question rated from 0 (no difﬁcult
3 (unable to do). The highest sub-scale
in each domain determines the score f
domain, unless assistance or devices a
used, where the category score is then
adjusted to the lower score or 2 (with m
difﬁculty or limited). Total score for the
is the mean of the scores of 8 categori
on a continuous scale 0e3
AIMS1/2 (1980, USA) Developed as a
multidimensional
index to measure
health status of individuals
suffering from various
arthritic conditions
56-item tool,
9 dimensions
Dimensions include:
mobility, physical
activity, dexterity,
activities of daily
living, social role,
social activity,
anxiety, depression
and pain
Responses for the items for each scale
standardised to 2 sets of 5 response
options (all dayseno days; always,
never or always, never), AIMS2 has
4 or 5 items for each scale
FIHOA (1993, France) Speciﬁc tool for evaluating
and monitoring symptoms
and functional repercussions
in hand osteoarthritis
10 questions Assessing functional
impact. Includes
daily ﬁne tasks
involving the hand
Each task asks: ‘Can you?’ and is ans
‘Possible without difﬁculty’ (scores 0), ‘
with difﬁculty’ (scores 1) or ‘impossible
(scores 2). An individual may have a s
between 0 and 20 on the index. Modiﬁ
version reports same questions. Amen
schedule: items rated on a 4 point scal
with difﬁculty’ is divided into: ‘possible
difﬁculty’ and ‘possible with slight difﬁcu
scale 0, 1, 2, 3. An individual may have
between 0 and 30 on the modiﬁed inde
Cochin
(1996, France)
Practical functional
disability scale. Originally
developed for rheumatoid
arthritis. Since been
evaluated in hand
osteoarthritis
18 questions
on activities of
daily living for
the hands
Assesses activities,
in the kitchen, in
dressing, hygiene,
at the ofﬁce and
‘other’
Each question answered on a 6 point
Likert scale from 0 (done without difﬁcu
(impossible to do). Total score derived
the score of each question. Total score
from 0 to 90
AUSCAN
(1997, Australia and
Canada)
Captures combination
of common symptoms
in hand osteoarthritis:
pain, stiffness
and physical functioning
15 items:
pain (5) stiffness
(1) physical
functioning (9)
Assesses: Pain
during activities e.g.,
pain at rest, pain when
gripping objects: hand
function relating
to difﬁculty with
hand activities
(e.g., taps, jars,
carrying pots):
One question
on severity of morning
stiffness in the last 48 h
For the Likert version (AUSCAN LK 3.0
responses are scaled on a 5 point
Likert scale (0Z none to 4Z extreme)
sub-scale scores calculated by summin
up the scores of the individual compon
The possible range of scores is 0e20 f
0e36 for function, and 0e4 for stiffness
The authors also suggest an overall
score generated by totalling the three s
scores, which ranges from 0 to 60. For
AUSCAN VA 3.0, items are scored on
visual analogue scale; 0e500 for pain,
function, and 0e100 for stiffness
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Background
Meenan et al.59 introduced the AIMS, a multidimensional
health status questionnaire, for use in sufferers of arthritis.
The main objective of this 56-item tool was to expand on the
current outcome measures that focussed mainly on the
impact of symptoms on physical health. It did this by
assessing nine dimensions (mobility, physical activity,
dexterity, ADL, social role, social activity, anxiety, de-
pression, and pain). Later work developed short-form
versions (SF AIMS)97,98, a version adapted for use in
elderly subjects (GERI AIMS)99, and subsequently a revised
and expanded version (AIMS2)48,62,67.
Conceptual framework
The AIMS was developed in the United States as
a multidimensional index to measure the health status of
individuals suffering from various arthritic conditions59. It
incorporated measures of mental and social well-being in
addition to the usual assessment of physical health. The
AIMS was a combination of two previously tested health
status measures: Bush’s Index of Well-being100 and the
Rand Health Insurance Study Batteries101, that addressed
concepts under the areas of mobility, physical activity,
social activity, anxiety and depression. Scales were added
to cover such areas as ADL, the social role, pain, and
dexterity59. The content was devised with ‘‘physician
importance’’ areas, and although patients were not involved
in the original development, the tool has subsequently been
shown to cover areas felt to be important for patients48,62.
The original AIMS has been revised and expanded
(AIMS2) with the main objectives of better addressing
arthritis relevant aspects and to address the importance of
patient satisfaction63. This new version was subjected to
validity and reliability tests and was seen to perform as well
as the original AIMS63.
Reliability
Internal consistency estimates for the AIMS scales were
0.63 or higher in the ﬁrst examination of the tool where it
was applied to 100 secondary care patients presenting with
a mix of arthritic conditions59. Reliability estimates were
also calculated across sub-groups differing in age, race,
gender, income, diagnosis (RA, OA, systemic lupus
erythematoso, and seronegative inﬂammatory arthritis), and
functional ability (classes I and II, classes III and IV) with the
set criteria for acceptance (Cronbach’s alphaO 0.7) being
achieved almost 90% of the time60. Testeretest correlations
were high across all scales (meanZ 0.87)61. The mea-
surement performance of the AIMS262 was assessed in 408
patients, of which 109 had OA. The arm function, and the
hand and ﬁnger function sub-scales performed well both in
terms of testeretest (0.92, 0.94) and internal consistency
(0.74, 0.87).
Validity
AIMS scores were shown to correlate well with external
measures such as overall health status, functional activity
and disease activity (both patient and physician reported)59.
In a pilot study of the AIMS2, 96% of subjects said that the
scales reﬂected nearly all the areas of importance and 58%
felt the scoring was at least satisfactory62.In comparison with AIMS2 hand and ﬁnger function sub-
scales in RA patients, OA patients rated their hand problems
as less a priority on self-designation of priority areas for
improvement62. Mason et al.102 demonstrated that the
scores for components of upper extremity function, effect,
and social factors were equivalent in both OA and RA
patients. However, differences between RA and OA patients
occurred in the symptom component, where pain was more
strongly associated with physical activity in OA than in RA102.
The GERI AIMS dexterity scale (yes/no scores) demon-
strated discriminate validity for three groups of subjects:
independent living (meanZ 1.37, SDZ 2.09), homebound
(meanZ 3.51, SDZ 3.89) and institutionalised (meanZ
2.13, SDZ 2.70)23.
Respondent and administrative burden
The AIMS takes approximately 20 min to self-administer
and the AIMS2, on average, 23 min (Table I).
Alternate forms
The AIMS was designed to be used as a self-adminis-
tered tool to be completed either in a clinical setting (i.e.,
waiting room) or at home, to be mailed back to the research
centre. Literature is not available to evaluate the instrument
when other modes of administration have been applied.
Cultural and language adaptations
In addition to the UK English versions48, the AIMS/AIMS2
has been translated into other languages103e111. In
addition, a French version of the long-form AIMS2 is
available and a Delphi technique and the Nominal Group
Process were used to derive a short-form version of the
AIMS2 in French47.
Relevance to populations with
HOA in primary care
Although the AIMS2 has been used in a variety of settings
in the USA, including with OA sufferers, there is no evidence
for its use in UK OA subjects in either primary care- or
population-based studies. The AIMS2 upper limb sub-scales
do not require any modiﬁcation from American to the English
language and so have the potential for being useful in
primary care- or population-based studies in the UK.
THE AUSTRALIAN/CANADIAN OSTEOARTHRITIS (AUSCAN)
HAND INDEX
Background
The AUSCAN12,13,37 was developed jointly between
Australia and Canada to provide a multi-cultural assess-
ment of hand function, pain and stiffness in OA. The
intention was to develop a reliable, valid and responsive
self-administered questionnaire to evaluate pain, stiffness,
and physical disability in trials of HOA12. The AUSCAN
contains 15 items that capture a combination of common
symptoms in HOA and those that occur frequently and are
important to symptomatic individuals.
Conceptual framework
The AUSCAN development was undertaken using the
same procedures to those used in the development and
validation of the WOMAC112. Items were generated from
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Convery index), opinions of clinicians (rheumatologists,
orthopaedic surgeon and physiotherapists) and patient
interviews. The collated items then underwent rationalisa-
tion utilising both clinical and statistical judgement criteria.
The ﬁrst stage provided questions for use in patient
interviews to generate an inventory12. Additional items were
added from interviews with HOA sufferers and a large pool
of items was generated. Utilising explicit exclusion criteria
the item list was reduced and tested using two methods of
scaling, a Likert (LK) scale and a VAS. Interviews were
undertaken with 50 symptomatic individuals with a diagnosis
of HOA. Questions were organised into three main
categories: pain during activities (10 items), stiffness (2
items) and physical function in different types of activity (83
items). Following an initial round of interviews the physical
function items were reduced to 27 and the ﬁnal candidate
items for the AUSCAN were based on the prevalence of the
symptom, the importance and the frequency of the
symptom.
The AUSCAN uses a 48-h time frame and comprises
sub-scales of hand pain (5 items), hand stiffness (1 item)
and hand function (9 items). Scoring methods are described
in Table I.
Reliability
Testeretest (1 week) reliability, in symptomatic individu-
als13 with a clinical classiﬁcation of HOA, was high for both
forms of the AUSCAN and for each of the three sub-scales
(ICCZ 0.70 to 0.90). Internal consistency, as measured by
Cronbach’s alpha was also high (0.90 to 0.98).
In a Tasmanian HOA family study29 construct validity
was assessed against the Dreiser index (rZ 0.76e0.96).
Testeretest reliability Cronbach’s alpha was reported as
0.82e0.9929. In an NSAID washout trial of 44 individuals
with symptomatic HOA, responsiveness was shown to be
high (P! 0.001) for all three sub-scales and for both forms
of the AUSCAN with average standardised response
means over a 6-week period ranging from 0.27 to
0.8413.
Validity
Construct validity was high (rO 0.40) for both forms and
each sub-scale of the AUSCAN when compared to the
FIHOA (original form, LK and VAS), the HAQ (disability and
pain), physician assessed tenderness and severity, and
patients’ global assessment of pain and function13.
Further validation of the instrument was undertaken
within the cross-sectional study of HOA in Tasmanian
families29. Kappa agreement between pain and disability
(AUSCAN 3 LK 3.0 sub-scales) and presence and severity
of HOA was ‘poor’ to ‘fair’. Total pain and function scores
were associated with gender, the carpometacarpal joint,
and the distal interphalangeal HOA scores in both uni-
variate and multi-variate analyses and these variables
explained 17% of the variation in pain. Spearman cor-
relation coefﬁcients demonstrated weak to moderate
associations between severity of HOA and function and
pain sub-scales.
The minimum change potentially detectable (MCPD) by
the AUSCAN has been reported as 1 unit and the minimum
percentage change potentially detectable (MPCPD) has
been reported as follows: pain 5%, stiffness 25%, physical
function 2.8% and AUSCAN total index score 1.7%113.Respondent and administrative burden
The instrument is self-completed, although no details
have been presented on the time taken for completion.
Alternate forms
The AUSCAN (LK 3.0, VAS 3.0) has been developed as
a self-administered instrument29. There is no evidence of
alternative administration approaches in the literature.
Cultural and language adaptations
The AUSCAN has been prepared and linguistically
validated in English (USA), Spanish, French, German,
Italian, Dutch and Norwegian13.
Relevance to populations with
HOA in primary care
The AUSCAN was used in a study primarily designed as
a family study into the genetics of HOA29. There is no
evidence for the use of the AUSCAN in unselected OA
subjects in either primary care- or population-based studies.
THE COCHIN SCALE
Background
The Cochin scale was developed by Duruoz et al.22 as
a practical functional disability scale for RA and hand
function. It is completed by the patient’s physician in a clinic
setting. The developers proposed that it would also be valid
and reliable for sufferers of HOA and have validated it for
use in OA33. The tool is therefore not HOA speciﬁc but for
use in hand arthritis (RA/OA).
Conceptual framework
The Cochin scale comprises 18 questions on ADL for the
hands (Table I). It was constructed in three stages; ﬁrstly,
from hand activities collected from published indices and
clinic assessments a functional scale was formulated,
secondly, a provisional scale was tested, and thirdly, the
ﬁnal scale was developed and tested for reliability and
validity with 102 RA patients22.
Principal components analysis identiﬁed four factors
accounting for 65% of the total variance33. These were:
grip, dexterity and precision, pinch strength and pinch
dexterity of the dominant hand.
Reliability
The inter-rater reliability in 41 patients with a clinical
diagnosis of HOA, at an interval of 1 h, was high
(ICCZ 0.96) and the mean difference in scores was 0.2
(SDZ 3.60).
Validity
The validity of the Cochin scale was tested in 89 HOA
sufferers attending an outpatient clinic. In terms of
convergent validity, the Cochin scale was shown to
correlate highly with Dreiser’s functional index and VAS
for handicap (rZ 0.67 to 0.87). The Cochin scale correlated
less well with radiographic lesions, manual joint assess-
ment and measures of pain and tenderness, all measures
7Osteoarthritis and Cartilage Vol. 13, No. 1chosen a priori to assess divergent validity. Cochin scale
scores were shown to deteriorate over an approximate 6-
month period and showed a standardised response mean
of 0.26 and an effect size of 0.17. Changes in the
Cochin scale compared to patient’s overall assessment
showed high correlation (rZ 0.47) and the mean change in
the Cochin scale was higher in those patients who self-
reported they had ‘‘improved’’ compared to those who had
‘‘deteriorated’’. Individual changes in Cochin scale were
highly correlated with individual changes in the outcome
measures used to assess convergent validity (rZ 0.57 to
0.65). Discriminative evidence using Spearman’s correla-
tion was rZ 0.51 for tenderness, rZ 0.32 for clinical
impairment and rZ 0.14 for X-ray change33.
Respondent and administrative burden
The Cochin scale is interviewer administered with a time
of completion reported as less than 3 min (Table I).
Alternate forms
The Cochin scale has only been interviewer administered
for clinic based HOA patients. There is no evidence of
alternative administration approaches in the literature.
Cultural and language adaptations
The Cochin scale was originally written in French and the
validity/reliability testing of the instrument has been in the
French language, although the scale has been translated
(forward and back translation) for use in English (USA)
speaking subjects, and has been published in English22,33.
Relevance to populations with HOA in primary care
There is no evidence for the use of the Cochin scale in
OA subjects in either primary care- or population-based
studies.
FUNCTIONAL INDEX OF HOA
Background
Dreiser et al.114 developed FIHOA for use in a clinic
based RCT of HOA, as no other tool existed at that time. It
was further developed for evaluation and symptomatic
follow-up of patients with digital ‘OA’20. The Index is based
on questions selected by clinicians as ‘‘most appropriate’’
for assessing the functional impact of active digital OA and
the authors claim that it is suitable for use in everyday
practice. The ﬁrst published version of the FIHOA can be
viewed in Dreiser et al.114. The content was determined by
the investigator and consists of 10 items involving daily ﬁne
tasks involving the hand. A modiﬁed version uses an
amended scoring system20.
Conceptual framework
The main aim of the FIHOA was to be a speciﬁc tool for
evaluating and monitoring symptoms and functional reper-
cussions in HOA. No information is given in any of the
publications on how the 10 tasks in the questionnaire were
chosen or why the speciﬁc items were included, only that
the items were chosen by clinicians114. The original and
modiﬁed versions20 are described in Table I.Reliability
For the FIHOA, a Cronbach’s alpha coefﬁcient of 0.85
was recorded for the questionnaire. Although the question-
naire was interviewer administered, no inter-interviewer
reliability was carried out due to the small number of
patients (within OA status) each interviewer saw. An intra-
patient reliability was carried out with patients completing
the FIHOA twice, 1 h apart. Mean difference in total score
was small, Kappas for individual items ranged between 0.68
and 0.87, and ICC for total score was 0.95420.
Validity
There is limited evidence on validity of the FIHOA,
however, very clear descriptions of methods used to collect
validity data are given. In an observational study, higher
FIHOA scores were seen for subjects with active OA
compared to those with inactive OA or no HOA20. The
FIHOA has been used as a primary outcome measure in
HOA RCTs21. In one RCT, FIHOA scores were shown to
correlate with global pain and overall efﬁcacy. In a second
RCT, FIHOA scores were shown to change over the 6-
month follow-up period with a mean standardised response
of 0.58 which was more sensitive than the objective
measures examined (e.g., grip strength) but not quite as
sensitive as pain measured on a VAS21. The MCPD by the
FIHOA (modiﬁed version 0e30 scale) has been reported as
1 unit and the MPCPD has been reported as 3.3%113.
Respondent and administrative burden
The FIHOA is interviewer administered with a mean time
of 2.35 min (SDZ 2 min) in subjects with painful joints. The
time of completion fell when administered a second time
(mean differenceZ 23 s, SDZ 56 s). All interviewers as-
signed a ‘good’ or ‘very good’ rating to the questionnaire for
ease of use. Ninety-eight percent of the patients rated the
questions as ‘easy’ or ‘very easy’ to answer. There were
missing data for three subjects (3%) in those with active
HOA.
Alternate forms
The FIHOA has only been interviewer administered for
clinic based OA patients. There is no evidence of alternative
administration approaches in the literature.
Cultural and language adaptations
The FIHOA was originally written in French and the
validity/reliability testing of the instrument has been in the
French language, although the index has been translated
for use in English speaking subjects, and has been
published in English21.
Relevance to populations with
HOA in primary care
There is no evidence for the use of the FIHOA in OA
subjects in either primary care- or population-based studies.
Comparative ratings
Table II provides a summary of the level of evidence
regarding each of the tools identiﬁed based on the review
criteria and Table III provides a summary of the overall
8 K. S. Dziedzic et al.: Systematic review hand OA disabilityperformance of each instrument according to the OMER-
ACT ﬁlter.
Discussion
The purpose of this review was to systematically identify
and critically appraise outcome measures for the speciﬁc
purpose of assessing hand disability in a UK population
survey in older people (aged 50 years and over). This paper
has examined ﬁve commonly used outcome tools in the
study of HOA (AIMS2, HAQ, AUSCAN, Cochin and
FIHOA). Of these instruments the AIMS2 and AUSCAN
were the most highly rated across the four main criteria
examined, although their applicability for use in UK
population surveys is unclear. The conceptual framework
of the FIHOA was not adequately described, whereas the
AUSCAN has more detailed evidence for this having been
developed in the same format as the WOMAC7. The FIHOA
and Cochin are interviewer administered which disadvan-
tages these tools. To be useful for a population survey,
a self-completion format needs to be validated. The
AUSCAN and the FIHOA have the advantage of being
speciﬁcally developed for HOA and have been recommen-
ded by OMERACT for use in clinical studies1. The HAQ has
been widely used in UK studies of arthritis and in population
surveys, demonstrating its popularity over the AIMS2. Its
main disadvantage is that a hand sub-scale was not
validated separately, although upper limb versions of the
HAQ have been developed83,84.
This review was performed systematically, using pre-
viously described criteria, three reviewers and well-deﬁned
objectives. It is limited by its inability to review outcome
measures under development. Instruments not qualifying,
Table II
Comparison of the measures of disability
Instrument Criteria
Conceptual and
measurement model
Reliability Validity
HAQ CC C CC
AIMS1/2 CC CCC CCC
FIHOA C CC CC
Cochin CC CC CC
AUSCAN CCC CCC CC
For each criterion reviewed the adequacy of supporting evidence
was rated and scored for extensive (CCC), adequate (CC),
limited (C), none (0) and unknown (?).
Table III
The evaluation of instruments according to the OMERACT filter
Instrument Truth
(conceptual
framework/
validity)
Discrimination
(sensitivity/
reliability)
Feasibility (respondent/
administrative burden,
alternate forms, cultural,
language adaptations)
HAQ CC C CC
AIMS1/2 CC CC CC
FIHOA CC CCC CC
Cochin CC CC CC
AUSCAN CCC CCC CC
For each OMERACT ﬁlter reviewed the adequacy of supporting
evidence was rated and scored for extensive (CCC), adequate
(CC), limited (C), none (0), and unknown (?).e.g., the DASH, might be appropriate and should be
considered for example if the focus was on outcome
following surgery (e.g., Ref.70). Instruments not qualifying
on grounds of not being adequately described in the
literature at the time of the review may fulﬁl the criteria at
a later date.
The aim of this review was not to recommend any one
instrument over another but to provide an overall review of
the robustness of commonly used measures. The results
have shown that all ﬁve instruments performed well. The
choice of instrument will depend on many factors, and will
differ from project to project depending on the question
asked. The potential users of these instruments should
base their instrument selection decision on the character-
istics that are most relevant to their particular outcome
need. In selecting an instrument to use there are a number
of factors that will inﬂuence choice including the population
selected (patient population, older population), setting
(hospital outpatient clinic, general practice surgery), mode
of administration (postal questionnaire) and time constraints
(use of short form or long versions).
As in the early days of systematic reviewing of RCTs,
important information was often missing which hindered
critical review of the instruments. It was therefore difﬁcult to
provide more than a detailed qualitative review of ﬁve
instruments according to set criteria. In developing new
outcome measures, consideration of the properties listed in
Appendix 1 will help future reviews of this kind.
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Appendix 1
Review Criteria (adapted from Refs.77,79).
Conceptual and measurement model
A conceptual model is the rationale for, and description
of, the concept that the measure is intending to assess and
the relationships between concepts. A measurement model
represents the operationalisation of the conceptual model in
terms of the basic elements (e.g., Which items are
combined to create scales?).
Reliability
Reliability is the degree to which an instrument is free
from random error. This is estimated by examining the
Scoring: adequacy of supporting evidence
{CCC extensive,
{CC adequate,
{C limited,
{ none,
{ ? unknown
9Osteoarthritis and Cartilage Vol. 13, No. 1extent to which similar scores are obtained with multiple
replications (i.e., items, occasions, raters). Internal consis-
tency (items, testeretest (occasions) and inter-rater (raters),
reliability) are often used to estimate the reliability of the
measurement process. The most common estimate of
reliability reported in the literature is internal consistency.
Minimum suggested internal consistency coefﬁcients range
from 0.50 to 0.70 for group comparisons, and 0.85e0.95
for individual comparisons. Kappa coefﬁcients are also
reported as an estimate of reliability that examines
the proportion of responses in agreement at separate
measurement points. Fleiss suggests kappa of less than
0.40 are poor, 0.40e0.59 are fair, 0.60e0.74 are good, and
greater than 0.74 are excellent. According to Landis and
Koch kappa of less than 0.0 are poor, 0.0e0.2 are
slightly poor, 0.21e0.40 are fair, 0.41e0.60 are moderate
and 0.61e0.80 are substantial, and 0.81e1 are almost
perfect.
Validity
Validity is the degree to which an instrument measures
what it purports to measure. Three types of evidence that
support an instrument’s validity are: content related,
criterion related and construct related. Content validity is
the extent to which a measure is judged to reﬂect the
appropriate range and depth of content. Criterion validity is
a measure of how well the instrument compares to a gold
standard but is rarely tested due to the lack of widely
accepted criterion measures. Construct validity is the extent
to which a measure behaves as expected (e.g., it correlates
in the expected or hypothesised direction and magnitude
with other measures with which it should be related
(convergent evidence) and with which it should not be
related (discriminate evidence)). Another aspect of con-
struct validity is the ability of an instrument to distinguish
between known groups (e.g., individuals with and without
a particular condition). The validity of a measure can also
be supported by its responsiveness or ability to detect
changes over time.
Respondent and administrative burden
Respondent burden is the time, effort and other demands
placed on those who respond to the instrument. Adminis-
trative burden is the demand on those who administer the
instrument.
Alternative forms
Alternative forms of an instrument include all those of
administration other than the original source instrument.
Evidence should be provided that supports the compara-
bility of the alternative mode of administration with that of
the original instrument.
Cultural and language adaptations
Information about methods used to achieve conceptual
and linguistic equivalents of cross-culturally adapted instru-
ments should be included. In addition, evidence should be
provided that the measurement properties of the adaptation
are comparable to the original instrument.References
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